-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Allogene Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2019 to Q2 2024.
- Allogene Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -43.2 %, a 3.1% increase year-over-year.
- Allogene Therapeutics, Inc. annual Return On Assets for 2023 was -45.5 %, a 21.9% decline from 2022.
- Allogene Therapeutics, Inc. annual Return On Assets for 2022 was -37.3 %, a 127% decline from 2021.
- Allogene Therapeutics, Inc. annual Return On Assets for 2021 was -16.4 %, a 42.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)